Key HighlightsJoby Aviation announces $500 million acquisition of Resonant Sciences to bolster defense capabilities.Acquisition brings more than $100 million in annual revenue to Joby’s defense operations.Shares decline 4.98% in premarket activity to $8.39 following previous session’s 1.97% gain to $8.81.Transaction includes secure facilities, radio frequency technology, and existing defense contracts.Deal anticipated to finalize during first half of 2027 pending regulatory clearance.Shares of Joby Aviation experienced early morning selling pressure following the company’s disclosure of a significant defense sector acquisition. Pre-market trading showed JOBY at $8.39, representing a 4.98% decline from the prior session’s closing price of $8.81, which had finished 1.97% higher. The aerospace firm revealed plans to purchase Resonant Sciences in a transaction valued at roughly $500 million.Joby Aviation, Inc., JOBYStrategic Defense Expansion Through Resonant Sciences BuyoutThis strategic acquisition positions Joby Aviation to significantly strengthen its defense technology portfolio with an operational business serving national security interests. Resonant Sciences maintains a financially healthy defense operation supporting ongoing United States security initiatives. The deal provides Joby with instant access to secure infrastructure, manufacturing operations, specialized personnel, and established governmental connections.Following regulatory clearance, Resonant Sciences will function as Joby’s specialized defense division. The acquired entity will maintain its current branding with J. Micah North continuing as chief executive. Joby plans to consolidate its current defense initiatives under this expanded operational unit.Current defense programs encompass turbine-electric aircraft development, hydrogen-powered electric platforms, and autonomous systems engineered for military and civilian applications. Joby’s commercial aviation segment will maintain its focus on electric air taxi regulatory approval and manufacturing operations. This organizational approach creates separation between defense technology development and Joby’s primary commercial aviation efforts while growing both divisions.Financial Performance and Technology Portfolio of Resonant SciencesResonant Sciences maintains a workforce of approximately 250 employees specializing in sophisticated radio frequency technologies for defense applications. The organization manufactures sensor systems, communication platforms, electronic warfare capabilities, and autonomous solutions. Its product lineup serves government entities and prominent defense industry contractors participating in multiple ongoing programs.Annual revenue grew approximately 40% year-over-year, surpassing $100 million over the trailing twelve-month period. The company achieved adjusted EBITDA margins in the high-teens range during recent reporting periods. Leadership anticipates improved profitability as manufacturing volumes scale across recently secured defense contracts.Order intake during the initial half of 2026 tripled compared to the prior year period. Simultaneously, Resonant’s contract backlog expanded to more than double the previous year’s levels. These metrics provide Joby with an established revenue foundation as it accelerates its defense technology initiatives.Expanded Manufacturing Footprint and Industrial CapabilitiesResonant Sciences maintains approximately 105,000 square feet of engineering and production facilities distributed across seven structures in the Dayton, Ohio area. The company is currently constructing an additional 125,000-square-foot complex to accommodate expanded testing, composite materials work, precision machining, and manufacturing operations. The organization also operates locations throughout Virginia, West Virginia, Michigan, Colorado, and North Carolina.Joby currently manages about 768,000 square feet of facilities in Ohio. The combined operations will deliver approximately one million square feet of manufacturing and testing infrastructure in the Dayton region. This expanded industrial base could accommodate larger defense programs while enhancing Joby’s overall aerospace manufacturing platform.The company plans to fund the acquisition with approximately $450 million in cash and $50 million in common shares. Transaction completion is targeted for the first half of 2027, contingent upon regulatory approvals and standard closing conditions. Meanwhile, JOBY shares continue trading beneath their most recent closing level following the early-session pullback. The post Joby Aviation (JOBY) Stock Declines Pre-Market Following $500M Resonant Sciences Acquisition Announcement appeared first on Blockonomi.